Name : Cynomolgus BAFFR/TNFRSF13C Protein
Product Source :
Recombinant Cynomolgus BAFFR/TNFRSF13C Protein is expressed from HEK293 with His tag at the C-Terminus. It contains Ser7-Ala71.[Accession | XP_001101623.2]
Molecular Weight :
The protein has a predicted MW of 7.7 kDa. Due to glycosylation, the protein migrates to 13-25 kDa based on Tris-Bis PAGE result.
Endotoxin Level :
Less than 1EU per μg by the LAL method.
Purity :
> 95% as determined by Tris-Bis PAGE
Formulation :
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution :
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage and Stability :
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3-6 months after reconstitution. 2-8°C for 2-7 days after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Product Concentration :
Tris-Bis PAGE Cynomolgus BAFFR on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. ELISA Data Immobilized Human BAFF (Trimer) , hFc Tag at 2μg/ml (100μl/well) on the plate. Dose response curve for Cynomolgus BAFFR, His Tag with the EC50 of 3.4ng/ml determined by ELISA (QC Test). ELISA Data Immobilized Cynomolgus BAFFR, His Tag at 1μg/ml (100μl/Well) on plate.Dose response curve for Anti-BAFFR Antibody, hFc Tag with the EC50 of 3.6ng/ml determined by ELISA.
Background :
BAFF binds to three TNF receptor superfamily members: B-cell maturation antigen (BCMA / TNFRSF17), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI/TNFRSF13B) and BAFF Receptor (BAFF R/BR3/TNFRSF13C). These receptors are type III transmembrane proteins that lack a signal peptide. Whereas TACI and BCMA bind BAFF and another TNF superfamily ligand, APRIL (a proliferation-inducing ligand), BAFF R selectively binds BAFF.
Synonyms :
CD268; BAFFR; BR3; TNFRSF13C; BROMIX; CVID4; prolixin
References & Citations :
(1)Tin K , Peng C , Christopher T , et al. BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE?/? Mice[J]. PLoS ONE, 2013, 8(4):e60430-.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
ICOS Protein
IL-2R beta/CD122 Protein
Popular categories:
Ubiquitin-Specific Protease 10
IFN-gamma R1